News
20m
Agence France-Presse on MSNUS health experts to reassess hormone replacement therapy risksUS health authorities are set Thursday to reassess Hormone Replacement Therapy (HRT), a treatment used by menopausal women ...
More than 67,000 cases of Power Stick deodorants were recalled for deviating from Food and Drug Administration standards.
The vaping company was once facing a federal ban under the Biden administration that was quickly suspended but thrust the future of Juul in doubt at one time.
SH-110, a liquid cancer treatment for glioma, earned orphan drug status from the FDA, helping patients who struggle to ...
Tarsus Pharmaceuticals' stock faces challenges despite XDEMVY's success. Analysts remain bullish with price targets of ...
The regulator authorized Juul Labs to keep its e-cigarettes on the U.S. market after a federal ban in 2022 had pushed the ...
Explore more
WASHINGTON - A.P. Deauville, LLC, has voluntarily recalled more than 67,000 cases of various Power Stick roll-on ...
Novartis is launching a $10 billion share buyback to be completed by year-end 2027 as new drug launches accelerate. | ...
As such, the FDA has classified the New Mexico Pinon Coffee pod recall as a Class III risk. The FDA defines such a risk as “a ...
The U.S. Food and Drug Administration has approved Juul's original vaporizer and refill cartridges in tobacco and menthol ...
Targeted Oncology connects oncology professionals with updates on immunotherapy, biomarkers, cancer pathways, and targeted ...
Health Secretary Robert F. Kennedy Jr. and other Trump officials are signaling their interest in approving psychedelic drugs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results